Ljubljana stock indices decline in lower turnover
Bosnia's Federation annual inflation slows down to 0.7% in Jan
Croatia's industrial PPI down 1.4% y/y in Jan
Most Romanian stock indices turn red
Romania's Holde Agri Invest widens net loss in 2023
Oct 19, 2022 14:30 EEST
October 19 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] has extended the validity of its binding offer for the purchase of 75% of the equity capital of local sector player Farmadent to November 3, Salus said on Wednesday.
Salus is still in talks for the acquisition of the 75% stake in Farmadent and hopes to sign an agreement for the transaction by November 3, Salus said in a filing with the Ljubljana Stock Exchange.
You can subscribe to our M&A newsletter here
Salus submitted a binding bid for the purchase of the stake in Farmadent on September 24 and set October 19 as a deadline for the validity of its offer.
The bid includes an option for the purchase of the remaining 25% stake in Farmadent, or alternatively the company's entire capital.
The potential acquisition of Farmadent is in line with Salus' development strategy, which envisages expansion of activities in regions where the company is not yet present.
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options